InvestorsHub Logo
Followers 14
Posts 649
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Saturday, 09/19/2015 5:58:04 PM

Saturday, September 19, 2015 5:58:04 PM

Post# of 461931
Nice correlation of sigma-1 targeting compounds disclosed..
Thanks for the link George to the MJFF/Anavex trial details. It was interesting to hear that MJFF has already funded a pre-clinical trial targeting Sigma-1 receptor compound ....and the results were reported very good..... and also Concert Pharma recently had very good results in pre-clinical trials with their sigma-1 agonist compound... and of course Anavex has had great results both pre-clinical and now from their P2aA ... So to me it seems the Sigma-1 targeting is clearly working , as evidenced by the above... Also, it is clear that MJFF knows a lot more about Sigma 1 science than has been discussed ...and clearly they did not grant to Anavex just because they had some kind of obligation to Anajex---like someone said on this board recently... BTW Anavex is way ahead of Concert Pharma in Sigma 1 receptor trials....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News